A facile method for the preparation of 7,8-dihydro-4H-chromene-4,5(6H)-diones as non-aromatic cycle A analogs of isoflavones and their evaluation as antiproliferative agents

  • Bioorg Chem. 2025 Oct:165:108960. doi: 10.1016/j.bioorg.2025.108960.
Dmitry B Rubinov  1 Veronica G Zinovich  1 Alexander M Scherbakov  2 Tatyana V Chukarina  1 Danila V Sorokin  3 Sviatlana E Ohurtsova  1 Elena V Shafranovskaya  1 Valeryia V Laptsevich  1 Alexandra L Mikhaylova  3 Fedor B Bogdanov  3 Alexander V Baranovsky  1 Raman M Puzanau  4 Yury G Pakhadnia  4 Fedor A Lakhvich  1 Yuri A Piven  5
Affiliations
  • 1. Institute of Bioorganic Chemistry, National Academy of Sciences of Belarus, Akad. Kuprevicha st. 5/2, Minsk 220084, Belarus.
  • 2. Department of Experimental Tumor Biology, N.N. Blokhin National Medical Research Center of Oncology, Kashirskoye Shosse 24 bldg.15, Moscow 115522, Russia; Gause Institute of New Antibiotics, Bol'shaya Pirogovskaya Ulitsa 11, Moscow 119021, Russia.
  • 3. Department of Experimental Tumor Biology, N.N. Blokhin National Medical Research Center of Oncology, Kashirskoye Shosse 24 bldg.15, Moscow 115522, Russia.
  • 4. Health Institution "National Anti-Doping Laboratory", ag. Lesnoy 31, Minsk Region 223040, Belarus.
  • 5. Institute of Bioorganic Chemistry, National Academy of Sciences of Belarus, Akad. Kuprevicha st. 5/2, Minsk 220084, Belarus. Electronic address: [email protected].
Abstract

In this article, we describe a facile method for the synthesis of a novel class of compounds - 3-aryl-7,8-dihydro-4H-chromene-4,5(6H)-diones. The target compounds were prepared from easily accessible 2-(2-arylacetyl)cyclohexane-1,3-diones using a low-cost dimethylformamide-dimethyl sulfate adduct in the presence of triethylamine. The obtained compounds, which can be considered non-aromatic cycle A analogs of Isoflavones, demonstrated moderate antiproliferative activity in the micromolar IC50 range and modest selectivity toward HER2-positive Cancer cells. A molecular modeling study suggested that their possible mechanism of action may involve HER2 inhibition. Additionally, by introducing a 3-chloro-4-((3-fluorobenzyl)oxy)phenyl group into the structure of the reported compounds, we designed and synthesized compound 4o as a potential selective HER2 inhibitor. Two compounds, 4b and 4o, which had different predicted binding modes to HER2, were tested in vitro for kinase activity inhibition against eight tyrosine kinases. At a concentration of 1 μM, compound 4b inhibited HER2 and HER4 by 74 % and 69 %, respectively. At the same concentration, compound 4o significantly inhibited only HER2 by 84 %. However, immunoblotting in A431 cells treated with 4b or 4o unexpectedly showed a reduction in total HER2 expression rather than in phosphorylated HER2 (p-HER2). Furthermore, both compounds reduced cyclin D1 level and stimulated PARP cleavage.

Keywords
7,8-dihydro-4H-chromene-4,5(6H)-diones; Antiproliferative activity; HER2; Isoflavones; Isoflavonoids.
Products